BIOMAT Database Logo BIOMAT Database Logo

HDL cholesterol efflux capacity and cardiovascular events. 2015

Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008297 Male Males
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann
HDL cholesterol efflux capacity and cardiovascular events.
May 2015, The New England journal of medicine,
Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann
HDL cholesterol efflux capacity and cardiovascular events.
May 2015, The New England journal of medicine,
Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann
HDL cholesterol efflux capacity and cardiovascular events.
May 2015, The New England journal of medicine,
Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann
HDL cholesterol efflux capacity and cardiovascular events.
May 2015, The New England journal of medicine,
Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann
HDL cholesterol efflux capacity and incident cardiovascular events.
December 2014, The New England journal of medicine,
Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann
HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease.
January 2017, Journal of the American College of Cardiology,
Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann
Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events.
August 2018, Journal of the American College of Cardiology,
Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann
HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target.
January 2016, Current atherosclerosis reports,
Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann
From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants.
April 2019, Current opinion in lipidology,
Chantal Kopecky, and Thomas Weichhart, and Marcus D Säemann
Psoriasis alters HDL composition and cholesterol efflux capacity.
August 2012, Journal of lipid research,
Copied contents to your clipboard!